GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Vivo Bio Tech Ltd

Vivo Bio Tech Q1 FY27 Consolidated Net Profit Rs. 18.76 Lacs

RESULTS ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 13 Jul 2026, 07:41 PM IST  ·  BSE ID: 23a5d3a0-3815-4749-b751-01cfeeb81ec9
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its financial results for the first quarter of the financial year 2026-27.
🤖 AI Summary
  • Vivo Bio Tech Board approved unaudited consolidated financial results for quarter ended June 30, 2026.
  • Consolidated revenue from operations for Q1 FY27 stood at Rs. 1,427.97 Lacs.
  • Consolidated net profit after tax was Rs. 18.76 Lacs for the quarter.
  • Standalone revenue from operations reached Rs. 1,413.94 Lacs for the same quarter.
  • Standalone net profit after tax recorded Rs. 18.43 Lacs in Q1 FY27.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Consolidated Revenue from operations (Q1 FY27)
1,427.97 Rs. in Lacs
14.13%
Consolidated Net Profit After Tax (Q1 FY27)
18.76 Rs. in Lacs
-85.95%
Standalone Revenue from operations (Q1 FY27)
1,413.94 Rs. in Lacs
13.86%
Standalone Net Profit After Tax (Q1 FY27)
18.43 Rs. in Lacs
-86.58%
🏢 How This Affects the Company
📈
Business Impact
The company reported consolidated revenue from operations of Rs. 1,427.97 Lacs for the quarter ended June 30, 2026.
💰
Financial Impact
Consolidated net profit after tax for the quarter was Rs. 18.76 Lacs. Total expenses for the consolidated entity amounted to Rs. 1,399.65 Lacs.
⚙️
Operational Impact
The company operates in a single segment, Bio Technology, indicating a focused operational structure.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reflected in the Q1 FY27 consolidated net profit after tax of Rs. 18.76 Lacs.
🔍
Management Signal
Management is focused on formal disclosure requirements by promptly announcing the quarterly financial results approved by the Board.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q2 FY27 results — check for sustained revenue growth and improved profitability.
Operating expense trends — analyze changes in employee costs and administrative expenditure.
Auditor's report for annual results — observe any qualifications or comments.
MEDIUM RISK Significant decrease in net profit after tax despite revenue growth indicates potential margin pressures or increased costs.
💡 Investor Takeaway
Vivo Bio Tech reported Q1 FY27 consolidated revenue from operations of Rs. 1,427.97 Lacs, an increase of 14.13% from Rs. 1,251.16 Lacs in Q1 FY26. However, consolidated net profit after tax decreased by 85.95% to Rs. 18.76 Lacs from Rs. 133.71 Lacs in Q1 FY26.
⚖️ Strengths & Concerns

✅ Positives

  • Consolidated revenue from operations for Q1 FY27 increased to Rs. 1,427.97 Lacs, up from Rs. 1,251.16 Lacs in Q1 FY26.
  • Standalone revenue from operations for Q1 FY27 increased to Rs. 1,413.94 Lacs, up from Rs. 1,241.86 Lacs in Q1 FY26.

⚠️ Concerns

  • Consolidated net profit after tax decreased to Rs. 18.76 Lacs in Q1 FY27 from Rs. 133.71 Lacs in Q1 FY26.
  • Standalone net profit after tax decreased to Rs. 18.43 Lacs in Q1 FY27 from Rs. 137.32 Lacs in Q1 FY26.
📅 Company Track Record
No previous filings found for this company in the provided context to establish specific historical trends or events. The company was incorporated in 1987 (CIN: L65993TG1987PLC007163).

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Vivo Bio Tech's consolidated net profit for Q1 FY27?
Vivo Bio Tech's consolidated net profit after tax for the quarter ended June 30, 2026, was Rs. 18.76 Lacs.
What was Vivo Bio Tech's consolidated revenue from operations in Q1 FY27?
The consolidated revenue from operations for Vivo Bio Tech for the quarter ended June 30, 2026, was Rs. 1,427.97 Lacs.
How did Vivo Bio Tech's standalone net profit compare year-over-year in Q1 FY27?
Standalone net profit after tax for Q1 FY27 was Rs. 18.43 Lacs, which is an 86.58% decrease compared to Rs. 137.32 Lacs in Q1 FY26.
Which subsidiaries are included in Vivo Bio Tech's consolidated results?
The consolidated results include Vivobio Labs Private Limited, Vivobio Discovery Services Private Limited, Surlogic Life Consultancy Private Limited, and Vivobio Consulting Services Private Limited.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.